Dow Plunges 622 to Open the Short Week as Oil's 'Crude Summer' Rally Hits Day Six

By Stocks News   |   2 months ago   |   Stock Market News
Dow Plunges 622 to Open the Short Week as Oil's 'Crude Summer' Rally Hits Day Six

98 problems and Brent ain’t is definitely one… 

So much for easing back in. Everybody came back from the glizzy weekend to see the Dow get pinned down 628 points, the S&P off 0.6%, and the Nasdaq fumble by 0.3%. Why? Because the U.S. and Iran are back on their B.S. again and oil smelled blood. 

In short, WTI climbed for a sixth straight day, its longest rally since a seven-day heater back in March, and Brent is hovering around $98 a barrel. Boo. What’s worse though is that nothing says de-escalation… the big brains in Tehran still want smoke, and crude is one bad headline from triple digits (terrific).

This, of course, brings us to the fun part. Missionary CPI lands Friday, with Thursday's PPI as the undercard, and both walk straight into the Fed's fly trap next week. The degens at CME FedWatch are pricing a 60% chance of a quarter-point HIKE, which, gulp. Bond traders already understood the assignment as the 10-year yield is sitting at levels last seen in November 2023, and the 2-year just hit a January 2025 high. And every day oil grinds higher is another round in the chamber for K-Woww. 

But, but, but… thank gawd the chip guys didn’t get the memo, or they ate it. The VanEck Semiconductor ETF gained 1.5% while the rest of the market bled. Intel surged more than 9% on reports it's raising PC chip prices about 10%… the stock is doing its best Chad Powers impression this year, up 178% after the whole league cut it… and AMD ran 6% with Broadcom tagging along for 3%. Oh, and Qualcomm popped 3% after inking a data center deal with Amazon Web Services that hands Amazon warrants on 25 million shares for a cool $4 billion. Meaning, Amazon only collects the full stack if it keeps buying Qualcomm gear for a decade. A prenup, basically. Memory stocks mooned again too, with Sandisk, Seagate, and Western Digital up between 3.5% and 9% on top of Friday's rip.

Elsewhere, in stonk land, the casualty list was ugly. Stryker fell 9% after admitting its peripheral vascular business is still riding the same supply-chain struggle bus that ran over Boston Scientific last month… the cyberattack-era manufacturing shutdown means the pain runs through Q3 and into Q4. Amgen slid almost 10% for a trial it wasn't even in (pour one out) as Novartis's rival cholesterol drug pelacarsen face-planted in Phase 3, dragging down hopes for Amgen's olpasiran ahead of data due in 2027 or early 2028. Naturally, BMO piled on with a downgrade and a price target implying a whopping 3% of upside. Woof. 

Over in software, Salesforce shed about 4% and the broader software ETF gave back 2% as everyone re-litigates whether GPT-6 Astra puts the sector in a body bag… while guys selling it the chips got paid. Now do the chipmakers, Sam… oh wait.

All in all, the four-day week is really just four days of killing time until Friday's CPI. If it comes in hot, K-Woww finally gets his first hike as chair… and you never forget your first. Until next time, friends…

If you read all of this, congrats for having a 10 second attention span (better than me). As always, here’s our heatmap for today.
 

☕ Market Gossip

> Chinese giants Xiaomi, Huawei race to get ahead of Apple’s rumored foldable iPhone (CNBC): Meanwhile, live look at Samsung… 

> Jefferies Fund Accuses Radiant World of Fraud Over Fake Invoices (Bloomberg): Super Micro be like: “First time?”

> Stoke Space raises another billion to rival SpaceX at re-flying rockets (TechCrunch): I’m guessing they are stoked? 

> Jim Cramer says OpenAI's new AI model is making Nvidia and Broadcom stocks look like big winners (Quartz): It was a good run, boys… 
 

“WTF” Meme of the Day

Now that’s a high-cap coin. (I’m not sure this is gonna end well.)
 

 

At the time of publishing, Stocks.News holds positions in Intel, Amazon, and Apple as mentioned in the article. 

 

Did you find this insightful?

Disclaimer: Information provided is for informational purposes only, not investment advice. We do not recommend buying or selling stocks. Stock price discussions are based on publicly available data. Readers should conduct their own research or consult a financial advisor before investing. Owners of this site have current positions in stocks mentioned throughout the site, Please Read Full Disclaimer for details Here https://app.stocks.news/page/disclaimer